Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 4369-4374

  Suresh, Madathilparambil V ^a   Singh, Sanjay K ^a   Ferguson Jr , Donald A ^a   Agrawal, Alok ^a,b  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; MUTANT PROTEIN; COMPLEMENT; LYSINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SERUM; SPECIES DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUTATION; SURVIVAL RATE;

ANIMALS; C-REACTIVE PROTEIN; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; HUMANS; LYSINE; MICE; MUTATION; PNEUMOCOCCAL INFECTIONS; SURVIVAL RATE; TYROSINE;

EID: 33646058924     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.4369     Document Type: Article

References (48)

1. Abernethy, T. J., and O. T. Avery. 1940. The occurrence during acute infections of a protein not normally present in ihe blood. I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J. Exp. Med. 73: 173-182.
2. Volanakis, J. E., and M. H. Kaplan. 1971. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136: 612-614.
3. Agrawal, A., M. J. Simpson, S. Black, M. P. Carey, and D. Samols. 2002. A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide. J. Immunol. 169: 3217-3222.
4. Kaplan, M. H., and J. E. Volanakis. 1974. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin, and sphingomyelin. J. Immunol. 112: 2135-2147.
5. Siegel, J., R. Rent, and H. Gewurz. 1974. Interactions of C-reactive protein complexes with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140: 631-647.
6. Claus, D. R., J. Siegel, K. Petras, A. P. Osmand, and H. Gewurz. 1977. Interactions of C-reactive protein with the first component of human complement. J. Immunol. 119: 187-192.
7. Gaboriaud, C., J. Juanhuix, A. Gruez, M. Lacroix, C. Darnault, D. Pignol, D. Verger, J. C. Fontecilla-Camps, and G. J. Arlaud. 2003. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J. Biol. Chem. 278: 46974-46982.
8. Kishore, U., R. Ghai, T. J. Greenhough, A. K. Shrive, D. M. Bonifati, M. Gadjeva, P. Waters, M. S. Kojouharova, T. Chakraborty, and A. Agrawal. 2004. Structural and functional anatomy of the globular domain of the complement protein C1q. Immunol. Lett. 95: 113-128.
9. Whitehead, A. S., K. Zahedi, M. Rits, R. F. Mortensen, and J. M. Lelias. 1990. Mouse C-reactive protein: generation of cDNA clones, structural analysis, and induction of mRNA during inflammation. Biochem. J. 266: 283-290.
10. Ku, N. O., and R. F. Mortensen. 1993. Cloning and tissue-specific expression of the gene for mouse C-reactive protein. Biochem. J. 295: 379-386.
11. Yother, J., J. E. Volanakis, and D. E. Briles. 1982. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J. Immunol. 128: 2374-2376.
12. Mold, C., S. Nakayama, T. J. Holzer, H. Gewurz, and T. W. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154: 1703-1708.
13. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1995. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155: 2557-2563.
14. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1996. Role of complement in C-reactive protein-mediated protection of mice from Streptococcus pneumoniae. Infect. Immun. 64: 4850-4853.
15. Mold, C., B. Rodic-Polic, and T. W. Du Clos. 2002. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J. Immunol. 168: 6375-6381.
16. Agrawal, A., and J. E. Volanakis. 1994. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J. Immunol. 152: 5404-5410.
17. Agrawal, A., A. K. Shrive, T. J. Greenhough, and J. E. Volanakis. 2001. Topology and structure of the C1q-binding site on C-reactive protein. J. Immunol. 166: 3998-4004.
18. Shrive, A. K., G. M. Cheetham, D. Holden, D. A. Myles, W. G. Turnell, J. E. Volanakis, M. B. Pepys, A. C. Bloomer, and T. J. Greenhough. 1996. Three dimensional structure of human C-reactive protein. Nat. Struct. Biol. 3: 346-354.
19. Thompson, D., M. B. Pepys, and S. P. Wood. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7: 169-177.
20. Agrawal, A., Y. Xu, D. Ansardi, K. J. Macon, and J. E. Volanakis. 1992. Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J. Biol. Chem. 267: 52552-52557.
21. Suresh, M. V., S. K. Singh, and A. Agrawal. 2004. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J. Biol. Chem. 279: 52552-52557.
22. Paik, G. 1980. Reagents, stains, and miscellaneous test procedures. In Manual of Clinical Microbiology, 3rd Ed. A. Balows, W. J. Hausler, Jr., and J. P. Traunt, eds. American Society for Microbiology, Washington D.C., pp. 1000-1024.
23. Brown, J. S., T. Hussell, S. M. Gilliland, D. W. Holden, J. C. Paton, M. R. Ehrenstein, M. J. Walport, and M. Botto. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. USA 99: 16969-16974.
24. Baltz, M. L., F. C. De Beer, A. Feinstein, E. A. Munn, C. P. Milstein, T. C. Fletcher, J. F. March, J. Taylor, C. Bruton, J. R. Clamp, et al. 1982. Phylogenetic aspects of C-reactive protein and related proteins. Ann. NY Acad. Sci. 389: 49-75.
25. Garlanda, C., B. Bottazzi, A. Bastone, and A. Mantovani. 2005. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23: 337-366.
26. Volanakis, J. E., and M. H. Kaplan. 1974. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J. Immunol. 113: 9-17.
27. Pepys, M. B., and M. L. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv. Immunol. 34: 141-212.
28. De Beer, F. C., M. L. Baltz, E. A. Munn, A. Feinstein, J. Taylor, C. Bruton, J. R. Clamp, and M. B. Pepys. 1982. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology 45: 55-70.
29. Mold, C., T. W. Du Clos, S. Nakayama, K. M. Edwards, and H. Gewurz. 1982. C-reactive protein reactivity with complement and effects on phagocytosis. Ann. NY Acad. Sci. 389: 251-262.
30. Reifenberg, K., H. A. Lehr, D. Baskal, E. Wiese, S. C. Schaefer, S. Black, D. Samols, M. Torzewski, K. J. Lackner, M. Husmann, et al. 2005. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler. Thromb. Vasc. Biol. 25: 1641-1646.
31. Padilla, N. D., W. K. Bleeker, Y. Lubbers, G. M. M. Rigter, G. J. V. Mierlo, M. R. Daha, and C. E. Hack. 2003. Rat C-reactive protein activates the autologous complement system. Immunology 109: 564-571.
32. Nakanishi, Y., H. Kodama, T. Murai, T. Mikami, and H. Izawa. 1991. Activation of rainbow trout complement by C-reactive protein. Am. J. Vet. Res. 52: 397-401.
33. Mold, C., H. Gewurz, and T. W. Du Clos. 1999. Regulation of complement activation by C-reactive protein. Immunopharmacology 42: 23-30.
34. Mold, C., and H. Gewurz. 1981. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. J. Immunol. 127: 2089-2092.
35. Jarva, H., T. S. Jokiranta, J, Hellwage, P. F. Zipfel, and S. Meri. 1999. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J. Immunol. 163: 3957-3962.
36. Suankratay, C., C. Mold, Y. Zhang, L. A. Potempa, T. F. Lint, and H. Gewurz. 1998. Complement regulation in innate immunity and the acute phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin. Exp. Immunol. 113: 353-359.
37. Zhang, Y., C. Suankratay, X.-H. Zhang, T. F. Lint, and H. Gewurz. 1999. Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology 42: 81-90.
38. Ren, B., M. A. McCrory, C. Pass, D. C. Bullard, C. M. Ballantyne, Y. Xu, D. E. Briles, and A. J. Szalai. 2004. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. J. Immunol. 173: 7506-7512.
39. Jarva, H., R. Janulczyk, J. Hellwage, P. F. Zipfel, L. Björck, and S. Meri. 2002. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168: 1886-1894.
40. Baltz, M. L., I. F. Rowe, and M. B. Pepys. 1985. In vivo turnover studies of C-reactive protein. Clin. Exp. Immunol. 59: 243-250.
41. 125I- labeled modified C-reactive protein in CD-1 mice. Drug Metab. Dispos. 26: 977-981.
42. Xia, D., and D. Samols. 1997. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. Sci. USA 94: 2575-2580.
43. Gould, J. M., and J. N. Weiser. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186: 361-371.
44. Black, S., A. Wilson, and D. Samols. 2005. An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. J. Immunol. 175: 1192-1196.
45. Mortensen, R. F., and W. Zhong. 2000. Regulation of phagocytic leukocyte activities by C-reactive protein. J. Leukocyte Biol. 67: 495-500.
46. Mold, C., W. Rodriguez, B. Rodic-Polic, and T. W. Du Clos. 2002. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J. Immunol. 169: 7019-7025.
47. Hirschfield, G. M., J. R. Gallimore, M. C. Kahan, W. L. Hutchinson, C. A. Sabin, G. M. Benson, A. P. Dhillon, G. A. Tennant, and M. B. Pepys. 2005. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 102: 8309-8314.
48. Trion, A., M. P. de Maat, J. W. Jukema, A. van der Laarse, M. C. Maas, E. H. Offerman, L. M. Havekes, A. J. Szalai, H. M. Princen, and J. J. Emeis. 2005. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler. Thromb. Vasc. Biol. 25: 1635-1640.